PFS Investments’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-47,947
Closed -$3.67M 411
2021
Q4
$3.67M Buy
47,947
+1,879
+4% +$166K 0.07% 226
2021
Q3
$4.84M Buy
46,068
+1,183
+3% +$129K 0.1% 182
2021
Q2
$5.13M Buy
44,885
+5,115
+13% +$503K 0.12% 160
2021
Q1
$3.56M Buy
39,770
+5,964
+18% +$656K 0.09% 186
2020
Q4
$3.33M Buy
33,806
+5,035
+18% +$375K 0.09% 178
2020
Q3
$1.41M Buy
28,771
+3,991
+16% +$192K 0.05% 222
2020
Q2
$1.01M Buy
24,780
+3,370
+16% +$96.8K 0.04% 209
2020
Q1
$330K Buy
21,410
+5,037
+31% +$106K 0.01% 231
2019
Q4
$371K Buy
+16,373
New +$269K 0.01% 213

Other funds holding CRNC

PFS Investments's CRNC Position: Q1 2022 in Review

PFS Investments sold out of Cerence (CRNC) in Q1 2022, closing a stake of 47,947 shares — an estimated $3.67M sold.

PFS Investments first reported a position in CRNC in Q4 2019 and held it in 9 quarters. The position peaked at $5.13M in Q2 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • PFS Investments reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • PFS Investments sold 47,947 Cerence shares in Q1 2022, an estimated $3.67M.
  • PFS Investments first reported a position in Cerence in Q4 2019 and held it in 9 quarters.
  • PFS Investments's Cerence position peaked at $5.13M in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on PFS Investments's 13F filing for Q1 2022, filed 16 May 2022.